by [email protected] | Jun 6, 2022 | Blog
It’s been a busy Spring conference season. Read more about our data and presentations below. We have access to more than 80% of the US healthcare system with patient-level data across all-provider types. See how we support evidence generation needs and let us...
by [email protected] | Mar 24, 2022 | Blog
Study Purpose and Population Epidemiology of rare diseases is important for clinicians to consider, as prevalence and incidence inform the healthcare community about likelihood of disease within an at-risk population. Studies in epidemiology also help to support...
by [email protected] | Mar 14, 2022 | Blog
STATinMED RWD Insights Our advisory and linkage services help clients to develop the ideal data lake, sourced with curated data that is aligned with research goals. With access to more than 80% of the US healthcare system, we use patient-level data across all-provider...
by [email protected] | Jan 31, 2022 | Blog
For years, market access teams within the biopharmaceutical industry have relied on regional, state and national medical and pharmacy covered lives data to size and scale their markets, identify targets, and set priorities for their strategy and contract negotiations....
by [email protected] | Jan 4, 2022 | Blog
Real-world data (RWD) and real-world evidence (RWE) are transforming the future of healthcare, including how Health Economics & Outcomes Research (HEOR) reveals the true burden of disease. Clinical trial data and payer-limited datasets are not enough to fully...
